(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

GUT REPRINT

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: US

Quick snapshot

GUT REPRINT

ST13

US500000098947800

Class

5, 10

Filing

98947800

Registration

8183176

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

Attention: there is active risk

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

27

Latest update

03/25/2026

Classification

Registered

Trademark type

Combined

Nice classes

5, 10

Filing date

01/09/2025

Registration date

03/24/2026

Expiration date

-

Recommended action

Perform a full collision analysis and validate classes before any filing or trademark investment.

Next step

These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.

Complete case details

Structured fields from the responsible authority and the official record.

Status date

03/24/2026

Last transaction

03/25/2026

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Drawing code

3

Owner type

99

Owner location

Lyon, FR

Examiner

GLUECK, CHRISTOPHER N

Law office

M30

Current location

FILE REPOSITORY (FRANCONIA)

Mark description

The mark consists of the stylized wording "GUT REPRINT" in blue; a stylized design of a digestive tract in purple with blue dots appearing within the tract is to the left of the stylized wording.

Holders and representatives

Holders

M. P. (pessoa física)

Representatives

Pina Campagna Carter, Deluca & Farrell, LLP

Technical classification

Nice Classes

Class 5Class 10

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Pharmaceutical and biopharmaceutical products and preparations for the medical treatment of gastrointestinal diseases and disorders emanating from microbiota dysfunction; veterinary preparations for the medical treatment of gastrointestinal diseases and disorders emanating from microbiota dysfunction; microorganism-based preparations for medical or veterinary use; bacterial preparations for medical or veterinary use; pharmaceutical and biopharmaceutical products and preparations comprising microorganism by-productsmeaning enzymesmetabolitessporesvesiclesnucleic acids and other small chemical compounds for human or veterinary use; microbiotherapy preparations for medical use for intestinal microbiome repair; cultures of microorganisms and biological tissue cultures for medical or veterinary use; Biological preparations for medical use for fecal transplantation or microbiome ecosystem therapies for restoring the intestinal microbiota; food and beverages comprising microorganisms or microorganism by-products adapted for medical or veterinary usefood supplements for humans and animals; medical plastersmaterials for dressingslint for medical purposes

Class 10

Medical and surgical apparatus and instruments for use in gastrointestinal surgery; drug delivery devicesin the nature of medical apparatus and instruments for administration of pharmaceutical and biopharmaceutical products and preparations in humans and animalssyringesinfusion sets and medical tubingimplantable devicessold empty; Drug delivery devices to treat gut microbiome-related disordersin the nature of a kit comprising a prefilled suspension bag and administration tube set sold without medication; enema apparatus for delivery of microorganism-based or microorganism by-products-based compositions and preparations; medical apparatus for fecal transplantation for restoring the intestinal microbiota; diagnostic apparatus for medical usediagnostic apparatus for medical diagnostic testing in the field of gut microbiota related diseases; testing apparatus for medical useapparatus for medical diagnostic testing in the field of gut dysbiosis related diseases; Medical diagnostic apparatusintestinal microbiota analysis apparatus for medical use; blood testing apparatus

Publications

History of USPTO decisions and trademark events.

27 publications found

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

03/24/2026

R.PR

REGISTERED-PRINCIPAL REGISTER

03/24/2026

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

02/03/2026

PUBO

PUBLISHED FOR OPPOSITION

02/03/2026

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

01/28/2026

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

01/09/2026

XAEC

EXAMINER'S AMENDMENT ENTERED

01/09/2026

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

01/09/2026

GNEA

EXAMINERS AMENDMENT E-MAILED

01/09/2026

CNEA

EXAMINERS AMENDMENT -WRITTEN

01/09/2026

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

12/02/2025

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

12/02/2025

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

12/02/2025

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

10/08/2025

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

10/08/2025

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

10/08/2025

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

10/06/2025

ECDR

TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS

10/06/2025

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

10/06/2025

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

10/06/2025

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

07/08/2025

GNRT

NON-FINAL ACTION E-MAILED

07/08/2025

CNRT

NON-FINAL ACTION WRITTEN

07/08/2025

DOCK

ASSIGNED TO EXAMINER

06/18/2025

MDSC

NOTICE OF DESIGN SEARCH CODE E-MAILED

06/08/2025

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

06/08/2025

NWAP

NEW APPLICATION ENTERED

01/09/2025

Continuous trademark protection

Get notified about every new filing that threatens GUT REPRINT or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.